Entrar/Registro  
HOME SPANISH
 
Cirugía y Cirujanos
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Cirugía y Cirujanos >Year 2013, Issue 2


Carrillo-Esper R, Carrillo-Cortes U, Carrillo-Córdova JR, Carrillo-Córdova LD, Carrillo-Córdova CA, Carrillo-Córdova DM
Hemolytic anemia secondary to the placement of a portosystemic Stented shunt
Cir Cir 2013; 81 (2)

Language: Español
References: 19
Page: 143-147
PDF: 1053.26 Kb.


Full text




ABSTRACT

Introduction: portal hypertension and variceal hemorrhage are common complications of hepatic cirrhosis, both associated with a high morbimortality. Portal system decompression by the placement of a transjugular intrahepatic portosystemic stented shunt, can reduce portal venus pressure and is effective controling complications of portal hypertension, like variceal hemorrhage and ascitis. The aim of this document is to describe a case of hemolytic anemia secondary to the placement of a transjugular intrahepatic portosystemic stented shunt.
Clinical case: patient with portal hypertension secondary to liver cirrosis which was placed transjugular intrahepatic portosystemic stented shunt for recurrent variceal hemorrhage. After the procedure, hemoglobin decreased 2 g/dL, associated with reticulocitosis, hipohaptoglobinemia, elevated lactic dehydrogenase and indirect hyperbilirrubinemia with negative Coombs test. The peripheral blood smear showed abnormal erythrocytes, with the prevalence of schistocytes. The final diagnosis was hemolytic anemia secondary to transjugular intrahepatic portosystemic stented shunt.
Conclusions: the hemolytic anemia secondary to Transjugular Intrahepatic Portosystemic Stented Shunt is a rare complication. Usually, it has a benign prognosis, and it’s self-limited once the stent is endothelialized.


Key words: portal hypertension, hemolytic anemia, crenocite, transjugular intrahepatic portosystemic stent shunt.


REFERENCIAS

  1. Carey W. Portal hypertension: Diagnosis and management with particular reference to variceal hemorrhage. J Dig Dis 2011;12(1):25-32.

  2. Richter GM, Palmaz JC, Nöldge G, Rössle M, Siegerstetter V, Franke M, et al. The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method. Radiologe 1989;29(8):406-411.

  3. Laberge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: Results in 90 patients. Gastroenterology 1995;108(4):1143-1151.

  4. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, et al. The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for Variceal Bleeding. N Engl J Med 1994;330:165-171.

  5. Ochs A, Rössle M, Haag K, Hauentein KH, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332(18):1192-1197.

  6. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP, Luketic VA, Cheatman AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt. Results of a prostpective controlled study. Hepatology 1994;20(1):46-55.

  7. Sanyal AJ, Freedman A, Purdum PP. Progressive encephalopathy and intravascular hemolysis following transjugular intrahepatic porto-caval stent-shunt (TIPSS). (Correspondence). Ann Int Med 1992;117:443-444.

  8. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrosis: a systematic review of 118 studies. J Hepatol 2006;44 (1):217-231.

  9. Garcia-Tsao G, Bosch J, Groszman RJ. Portal Hypertension and Variceal Bleeding-Unresolved Issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver Single-Topic Conference. Hepatology 2008;47(5):1764-1772.

  10. Mihas AA, Sanyal AJ. Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology 2004;127(2):621-629.

  11. Collins JC, Sarfeh IJ. Surgical Management of Portal Hypertension. West J Med 1995;162(6):527-535.

  12. Conn HO. Hemolysis After Transjugular Intrahepatic Portosystemic Shunting: The Naked Stent Syndrome. Hepatology 1996;23(1):177-181.

  13. Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996;23(1):32-39.

  14. Jalan R, Redhead DN, Allan PL, Hayes PC. Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic Stent-Shunt (TIPSS). Eur J Gastroenterol Hepatol 1996;8(4):381-385.

  15. Riggio O, Ricci G, Zullo A, Merli M, Girelli G, Rossi P, et al. Intravascular hemolysis and transjugular intrahepatic portosystemic stent shunt. J Hepatol 1994;20(1):152-153.

  16. Cheng KH, Laméris JS, de Man RA, Pieterman H, van Buuren HR. Haemolysis and cholestasis following implantation of a transjugular intrahepatic portosystemic shunt. Eur J Gastroent Hepatol 1994;6(8):749-751.

  17. Garcia-Rebollo S, González-Reimers E, Santolaria-Fernández F, Díaz-Romero F, Rodríguez-Moreno F, Martínez-RieraA. Transiet Hemolytic Anemia after Transjugular Intrahepatic Portosystemic Stent Shunt. HBP Surgery 1996;9(4):249-251.

  18. Uchman S, Citnavis V, Haas R. Hemolysis: complication of transjugular intrahepatic portosystemic shunt (TIPS). (Abstract) Hepatology 1993;18:288(A).

  19. Rank J, Herman M, Foshager M. A prospective study of hemolysis following transjugular intrahepatic shunts (TIPS) using CO breath testing. (Abstract) Gastroenterology 1994;106:A968.






>Journals >Cirugía y Cirujanos >Year 2013, Issue 2
 

· Journal Index 
· Links 






       
Copyright 2019